Next Issue

June 2025

Don’t miss out – sign up to our free industry-leading magazine and newsletters

In the next issue, we will check in with the FDA’s Priority review programme for pediatric rare diseases and how its entry into the ‘sunsetting’ phase can affect drug development efforts. We will also explore the nascent research behind in utero treatments for genetic disorders.

EDITORIAL

Editor | Manasi Vaidya

Deputy Editor | Ross Law

Writers | Robert Barrie, Abigail Beaney, Frankie Fattorini, Jenna Philpott

Graphic Designers | Anett Arc, Noemi Balint, Will Ingham, Miriam Garofalo

ADVERTISING

Sales Manager | Tom McCormick
+44 207 8669440

Pharma Technology Focus is powered by H5mag
Read past issues of Pharma Technology Focus here

Go to article: Home | The GLP-1 drug shortage is over. What’s next for the compounders?Go to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: MilliporeSigmaGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Molnar-Institute Company InsightGo to article: Molnar-InstituteGo to article: ZETAGo to article: In DepthGo to article: The GLP-1 drug shortage is over. What’s next for the compounders?Go to article: Big pharma faces headwinds in China as vaccine sales declineGo to article: How can pharma manage rising trial costs?Go to article: Can AI replace medical writers? Experts say not immediatelyGo to article: Saving shelved ultra-rare therapies through unorthodox fundingGo to article: Do in vivo CAR-T cell therapies have the potential to overtake ex vivo CAR-Ts?Go to article: Weight loss implants to increase compliance and cut admin burden for patientsGo to article: Greens Company InsightGo to article: ListingsGo to article: EventsGo to article: Excellence AwardsGo to article: Buyer's GuidesGo to article: Next issue